Covariate | Patients receiving BI (N=113) Mean (%/±SD) | Patients receiving OAD (N=408) Mean (%/±SD) | p Value |
---|---|---|---|
Age (years) | 57.4 (±12.8) | 56.4 (±12.7) | 0.46 |
Female gender | 45 (39.8) | 185 (45.3) | 0.34 |
Height (cm) | 171.9 (±9.5) | 170.3 (±10.1) | 0.14 |
Weight (kg) | 90.8 (±20.9) | 91.9 (±20.2) | 0.63 |
Diabetes-related variables | |||
Diabetes duration (years) | 0.6 (±0.7) | 0.5 (±0.6) | 0.03 |
HbA1c (%) | 8.6 (±2.3) | 7.6 (±2.1) | <0.001 |
FPG (mmol/L) | 8.6 (±3.1) | 7.7 (±3.2) | 0.01 |
PPG (mmol/L) | 10.7 (±5.9) | 9.7 (±9.1) | 0.17 |
Comorbidities/risk factors | |||
Prior microvascular diseases | 21 (18.6) | 50 (12.3) | 0.09 |
Prior macrovascular diseases | 17 (15.0) | 30 (7.4) | 0.02 |
Prior hypoglycemic event | 0 (0.0) | 0 (0.0) | – |
Smoking | 55 (48.7) | 149 (36.5) | 0.06 |
Bold indicates significance. p Values for continuous data were provided by pooled univariate linear regression models. p Values for dichotomous variables correspond to Fisher’s exact tests. p Value for smoking provided by pooled logistic regression.
BI, basal insulin; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; OAD, oral antidiabetic medicine; PPG, postprandial plasma glucose.